Press release
Investigation announced for former Investors in formerly Avedro, Inc. (Nasdaq: AVDR , now Glaukos Corporation (NYSE: GKOS)
An investigation for investors in formerly Avedro, Inc. (Nasdaq: AVDR), now Glaukos Corporation (NYSE: GKOS) shares.
Investors who held Avedro, Inc. (Nasdaq: AVDR) shares and received shares of Glaukos Corporation (NYSE: GKOS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Clemente, CA based Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma.
On August 7, 2019, Avedro, Inc’s Board of Directors caused the Company to enter into an agreement and plan of merger with Glaukos. Pursuant to the terms of the Merger Agreement, Avedro, Inc’s stockholders will receive 0.365 shares of Glaukos Corporation (NYSE: GKOS common stock for each share of Avedro, Inc. (Nasdaq: AVDR) common stock they own.
In November 2019, Glaukos Corporation (NYSE: GKOS) completed its merger with Avedro, Inc. (Nasdaq: AVDR).
Shares of Glaukos Corporation (NYSE: GKOS) declined from $75 per share in July 2019 to as low as $23.31 per share in March 2020.
Those who purchased shares of Glaukos Corporation (NYSE: GKOS) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for former Investors in formerly Avedro, Inc. (Nasdaq: AVDR , now Glaukos Corporation (NYSE: GKOS) here
News-ID: 2186871 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Glaukos
Keratoconus Therapeutics Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Keratoconus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Keratoconus, historical and forecasted epidemiology as well as the Keratoconus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover which therapies are expected to grab the Keratoconus Market Share @ Keratoconus Market Outlook- https://www.delveinsight.com/sample-request/keratoconus-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Keratoconus Market Report
• In February 2025, Epion Therapeutics announced a phase…
Gel Stent Market Generated Opportunities, Future Scope 2025-2032 | Allergan, Alc …
The latest report (2025-2032) on the Gel Stent Market by Coherent Market Insights offers an in-depth analysis of market trends, growth factors, challenges, and competition. It explores market size, revenue, production, consumption, and CAGR, using reliable research methods for accuracy. The report also covers technological advancements, pricing trends, consumer behavior, and investment opportunities, helping businesses make smart decisions and stay competitive.
With a focus on Market growth and future opportunities, this…
Global Ophthalmic Devices Market | Clearlab SG PTE, Ltd. EssilorLuxottica SA Gla …
Global Ophthalmic Devices Market Report published by Astute Analytica provides insight and updates about the corresponding segments involved in the global market for the forecast period of 2021-2027. A detailed analysis of the market dynamics is provided and comprehensive data about the structure of the industry. The Global Ophthalmic Devices Market Research Study contains exclusive insights into the market's forecast growth.
Global Ophthalmic Devices Market is expected to witness market growth…
Glaukos Corporation (NYSE: GKOS) Investor Notice: Investigation for former Avedr …
An investigation on behalf of investors of former Avedro, Inc. (Nasdaq: AVDR),who received shares of Glaukos Corporation (NYSE: GKOS) over potential securities laws violations in connection with certain statements.
Investors who purchased shares of Glaukos Corporation (NYSE: GKOS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on concerning whether certain statements by Glaukos Corporation regarding…
Gel Stent Market Key companies Profile Allergan, Alcon, Innfocus and Glaukos Cor …
Stent is a small expandable tube used for the treatment of narrowed arteries. It is used to prevent bursting of arteries and improve blood flow of weak arteries. Soft gelatin is used for the preparation of gel stent. When gel stent is injected, it gets hydrated and drains the aqueous humor in the sub-conjunctival space, which lowers the intraocular pressure. This procedure is minimally invasive.
Gel Stent Market – Dynamics
Rising population…
Gel Stent Market Evolving Technology, Trends and Top Players Allergan, Alcon, In …
Stent is a small expandable tube used for the treatment of narrowed arteries. It is used to prevent bursting of arteries and improve blood flow of weak arteries. Soft gelatin is used for the preparation of gel stent. When gel stent is injected, it gets hydrated and drains the aqueous humor in the sub-conjunctival space, which lowers the intraocular pressure. This procedure is minimally invasive.
Gel Stent Market – Dynamics
Rising population…
